AbbVie's MAVIRET receives positive opinion from European regulator
Enhertu recommended for EU approval in previously treated HER2 positive metastatic solid tumours
Bayer's KERENDIA receives FDA priority review for type 1 diabetes and kidney disease treatment
Upsher-Smith launches generic Cyclosporine Ophthalmic Emulsion 0.05%
Medtronic plans to SPR Therapeutics for USD650m to expand pain management portfolio
Implantica submits final FDA response for RefluxStop PMA application
Hansa Biopharma signs EUR115m IDEFIRIX licensing deal with SERB
Lupin receives tentative FDA approval for Revefenacin Inhalation Solution
Artivion completes acquisition of Endospan following FDA approval of NEXUS Aortic Arch System
AstraZeneca wins US approval for Baxfendy as first aldosterone synthase inhibitor for hypertension
Akeso reports results from Phase II trial of ligufalimab combination therapy in AML